RAIN - RAIN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Rain Oncology to Pathos AI via a Tender Offer | Benzinga
MONSEY, N.Y., Dec. 21, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $1.16 per share in cash, plus a contingent value right ("CVR") for up to $0.17 per share in cash, at which Rain Oncology, Inc. (NASDAQ:RAIN) ("RAIN") has agreed to be sold to Pathos AI, Inc. ("Pathos") via a tender offer.
If you remain a RAIN shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge:
https://wohlfruchter.com/cases/rain-oncology/
Alternatively, you may contact us by phone ...